Kiseleva Yana V, Zharikova Tatiana S, Maslennikov Roman V, Temirbekov Shikhsaid M, Olsufieva Anna V, Polyakova Olga L, Pontes-Silva André, Zharikov Yury O
Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101455. doi: 10.1016/j.jceh.2024.101455. Epub 2024 Jun 8.
Liver regeneration (LR) is a unique biological process with the ability to restore up to 70% of the organ. This allows for the preservation of liver resections for various liver tumors and for living donor liver transplantation (LDLT). However, in some cases, LR is insufficient and interventions that can improve LR are urgently needed. Gut microbiota (GM) is one of the factors influencing LR, as the liver and intestine are intimately connected through the gut-liver axis. Thus, healthy GM facilitates normal LR, whereas dysbiosis leads to impaired LR due to imbalance of bile acids, inflammatory cytokines, microbial metabolites, signaling pathways, etc. Therefore, GM can be considered as a new possible therapeutic target to improve LR. In this review, we critically observe the current knowledge about the influence of gut microbiota (GM) on liver regeneration (LR) and the possibility to improve this process, which may reduce complication and mortality rates after liver surgery. Although much research has been done on this topic, more clinical trials and systemic reviews are urgently needed to move this type of intervention from the experimental phase to the clinical field.
肝再生(LR)是一个独特的生物学过程,能够使肝脏恢复高达70%的功能。这使得各种肝脏肿瘤的肝切除术以及活体肝移植(LDLT)得以开展。然而,在某些情况下,肝再生并不充分,因此迫切需要能够改善肝再生的干预措施。肠道微生物群(GM)是影响肝再生的因素之一,因为肝脏和肠道通过肠-肝轴紧密相连。因此,健康的肠道微生物群有助于正常的肝再生,而生态失调则会由于胆汁酸、炎性细胞因子、微生物代谢产物、信号通路等的失衡导致肝再生受损。所以,肠道微生物群可被视为改善肝再生的一个新的潜在治疗靶点。在本综述中,我们批判性地审视了目前关于肠道微生物群(GM)对肝再生(LR)影响的知识,以及改善这一过程的可能性,这可能会降低肝脏手术后的并发症和死亡率。尽管关于这个主题已经开展了大量研究,但仍迫切需要更多的临床试验和系统评价,以便将这类干预措施从实验阶段推进到临床应用领域。